1.           Introduction

1.1         Study Scope

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Asia Pacific Lung Cancer Screening Market – by Technology

1.3.2        Asia Pacific Lung Cancer Screening Market – by Cancer Type

1.3.3        Asia Pacific Lung Cancer Screening Market – by Age Group

1.3.4        Asia Pacific Lung Cancer Screening Market – by End User

1.3.5        Asia Pacific Lung Cancer Screening Market – by Country

2.           Asia Pacific Lung Cancer Screening Market –  Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Lung Cancer Screening Market – Market Landscape

4.1         Overview

4.2         Asia Pacific PEST Analysis

4.3         Expert’s Opinion

5.           Asia Pacific Lung Cancer Screening Market –  Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Lung Cancer Incidences

5.1.2        Increasing Government Support

5.2         Market Restraints

5.2.1        High Cost of Lung Cancer Screening Tests

5.3         Market Opportunities

5.3.1        Structured Lung Cancer Screening Program

5.4         Future Trends

5.4.1        Mobile Lung Cancer Screening Truck

5.5         Impact Analysis

6.           Asia Pacific Lung Cancer Screening Market – Asia Pacific Analysis

6.1         Asia Pacific Lung Cancer Screening Market Revenue Forecast and Analysis

7.           Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2028 – By Cancer Type

7.1         Overview

7.2         Asia Pacific Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)

7.3         Non–Small Cell Lung Cancer (NSCLC)

7.3.1        Overview

7.3.2        Non–Small Cell Lung Cancer (NSCLC): Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Mn)

7.4         Small Cell Lung Cancer

7.4.1        Overview

7.4.2        Small Cell Lung Cancer: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

8.           Asia Pacific Lung Cancer Screening Market Analysis – by Technology

8.1         Overview

8.2         Low-Dose Computed Tomography (LDCT)

8.2.1        Overview

8.2.2        Low-Dose Computed Tomography (LDCT): Asia Pacific Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

8.3         Chest X-ray

8.3.1        Overview

8.3.2        Chest X-ray: Asia Pacific Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

8.4         Liquid Biopsy

8.4.1        Overview

8.4.2        Liquid Biopsy: Asia Pacific Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

8.5         Others

8.5.1        Overview

8.5.2        Others: Asia Pacific Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

9.           Asia Pacific Lung Cancer Screening Market Analysis – by Age Group

9.1         Overview

9.2 & Older

9.2.1        Overview

9.2.2 & Older: Australia Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

9.3         Below 50

9.3.1        Overview

9.3.2        Below 50: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

10.        Asia Pacific Lung Cancer Screening Market Analysis – by End User

10.1      Overview

10.2      Hospitals

10.2.1     Overview

10.2.2     Hospitals: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

10.3      Diagnostic Centers

10.3.1     Overview

10.3.2     Diagnostic Centers: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

10.4      Others

10.4.1     Overview

10.4.2     Others: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

11.        Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2028 – Country Analysis

11.1      Asia Pacific Lung Cancer Screening Market

11.1.1.1       China: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.1.1       Overview

11.1.1.1.2       China: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.1.3       China: Asia Pacific Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.1.4       China: Asia Pacific Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

11.1.1.1.5       China: Asia Pacific Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.1.6       China: Asia Pacific Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

11.1.1.2       Japan: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.2.1       Overview

11.1.1.2.2       Japan: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.2.3       Japan: Asia Pacific Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.2.4       Japan: Asia Pacific Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

11.1.1.2.5       Japan: Asia Pacific Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.2.6       Japan: Asia Pacific Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

11.1.1.3       India: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.3.1       Overview

11.1.1.3.2       India: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.3.3       India: Asia Pacific Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.3.4       India: Asia Pacific Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

11.1.1.3.5       India: Asia Pacific Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.3.6       India: Asia Pacific Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

11.1.1.4       Australia: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.4.1       Overview

11.1.1.4.2       Australia: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.4.3       Australia: Asia Pacific Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.4.4       Australia: Asia Pacific Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

11.1.1.4.5       Australia: Asia Pacific Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.4.6       Australia: Asia Pacific Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

11.1.1.5       South Korea: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.5.1       Overview

11.1.1.5.2       South Korea: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.5.3       South Korea: Asia Pacific Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.5.4       South Korea: Asia Pacific Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

11.1.1.5.5       South Korea: Asia Pacific Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.5.6       South Korea: Asia Pacific Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

11.1.1.6       Rest of Asia Pacific: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.6.1       Overview

11.1.1.6.2       Rest of Asia Pacific: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

11.1.1.6.3       Rest of Asia Pacific: Asia Pacific Lung Cancer Screening Market, by Cancer Type, 2020-2030 (US$ Million)

11.1.1.6.4       Rest of Asia Pacific: Asia Pacific Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

11.1.1.6.5       Rest of Asia Pacific: Asia Pacific Lung Cancer Screening Market, by Age Group, 2020-2030 (US$ Million)

11.1.1.6.6       Rest of Asia Pacific: Asia Pacific Lung Cancer Screening Market, by End User, 2020-2030 (US$ Million)

12.        Asia Pacific Lung Cancer Screening Market–Industry Landscape

12.1      Recent Growth Strategies

12.1.1     Overview

13.        Company Profiles

13.1      Intelerad Medical Systems

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Nuance Communications Inc

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      GE HealthCare

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Medtronic

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Canon Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      Koninklijke Philips NV

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      Siemens AG

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

14.        Appendix

14.1      About The Insight Partners

14.2      Glossary of Terms

LIST OF TABLES

Table 1.             China: Asia Pacific Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)

Table 2.             China: Asia Pacific Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 3.             China: Asia Pacific Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 4.             China: Asia Pacific Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 5.             Japan: Asia Pacific Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)

Table 6.             Japan: Asia Pacific Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 7.             Japan: Asia Pacific Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 8.             Japan: Asia Pacific Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 9.             India: Asia Pacific Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)

Table 10.          India: Asia Pacific Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 11.          India: Asia Pacific Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 12.          India: Asia Pacific Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 13.          Australia: Asia Pacific Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)

Table 14.          Australia: Asia Pacific Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 15.          Australia: Asia Pacific Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 16.          Australia: Asia Pacific Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 17.          South Korea: Asia Pacific Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)

Table 18.          South Korea: Asia Pacific Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 19.          South Korea: Asia Pacific Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 20.          South Korea: Asia Pacific Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 21.          Rest of Asia Pacific Lung Cancer Screening Market, by Cancer Type – Revenue and Forecast to 20228 (US$ Million)

Table 22.          Rest of Asia Pacific Lung Cancer Screening Market, by Technology – Revenue and Forecast to 2030 (US$ Million)

Table 23.          Rest of Asia Pacific Lung Cancer Screening Market, by Age Group – Revenue and Forecast to 2030 (US$ Million)

Table 24.          Rest of Asia Pacific Lung Cancer Screening Market, by End User – Revenue and Forecast to 2030 (US$ Million)

Table 25.          Recent Growth Strategies in the Asia Pacific Lung Cancer Screening Market

Table 26.          Glossary of Terms

LIST OF FIGURES

Figure 1.           Asia Pacific Lung Cancer Screening Market Segmentation

Figure 2.           Asia Pacific Lung Cancer Screening Market, by Country

Figure 3.           Asia Pacific Lung Cancer Screening Market Overview

Figure 4.           Non-Small Cell Lung Cancer Segment Held Largest Share of Cancer Type Segment in Asia Pacific Lung Cancer Screening Market

Figure 5.           Asia Pacific Expected to Show Remarkable Growth During Forecast Period

Figure 6.           Asia Pacific: PEST Analysis

Figure 7.           Experts’ Opinion

Figure 8.           Asia Pacific Lung Cancer Screening Market Impact Analysis of Driver and Restraints

Figure 9.           Asia Pacific Lung Cancer Screening Market – Revenue Forecast and Analysis – 2020-2030

Figure 10.        Asia Pacific Lung Cancer Screening Market Revenue Share, by Cancer Type 2022 & 2030 (%)

Figure 11.        Non–Small Cell Lung Cancer (NSCLC): Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 12.        Small Cell Lung Cancer: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 13.        Asia Pacific Lung Cancer Screening Market, by Technology, 2022 & 2030 (%)

Figure 14.        Low-Dose Computed Tomography (LDCT): Asia Pacific Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 15.        Chest X-ray: Asia Pacific Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 16.        Liquid Biopsy: Asia Pacific Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 17.        Others: Asia Pacific Lung Cancer Screening Market– Revenue and Forecast to 2030 (US$ Million)

Figure 18.        Asia Pacific Lung Cancer Screening Market, by Age group, 2022 & 2030 (%)

Figure 19.       50 & Older: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 20.        Below 50: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 21.        Asia Pacific Lung Cancer Screening Market, by End User, 2022 & 2030 (%)

Figure 22.        Hospitals: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 23.        Diagnostic Centers: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 24.        Others: Lung Cancer Screenings Market – Revenue and Forecast to 2030 (US$ Million)

Figure 25.        Asia Pacific Lung Cancer Screening Market, by Key Country – Revenue (2022) (US$ Million)

Figure 26.        Asia Pacific Lung Cancer Screening Market Revenue Share, by Country, 2022 & 2030 (%)

Figure 27.        China: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 28.        Japan: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 29.        India: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 30.        Australia: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 31.        South Korea: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)

Figure 32.        Rest of Asia Pacific: Asia Pacific Lung Cancer Screening Market – Revenue and Forecast to 2030 (US$ Million)